Tuesday, May 02, 2017 8:24:05 AM
May 2, 2017 8:07 AM ET|About: Momenta Pharmaceuticals... (MNTA)|By: Mohit Manghnani, SA News Editor
Momenta Pharmaceuticals (NASDAQ:MNTA): Q1 EPS of -$0.46 beats by $0.03.
Revenue of $26.6M (+34.0% Y/Y) beats by $2.11M.
https://seekingalpha.com/news/3262124-momenta-pharmaceuticals-beats-0_03-beats-revenue?uprof=45
Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • BLOZF • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
